INTRODUCTION
Conjugated fatty acid is a generic term used for fatty acids with conjugated double bonds, as exemplified by conjugated linoleic acid CLA 1 . There are several CLA isomers due to positional and geometrical isomerism of the conjugated double bonds, and the major naturally-occurring CLA isomer is referred to as 9c,11t-18:2 Fig. 1 1 .
CLAs were first reported to have an anti-tumor effect, and subsequently various physiological effects have been shown, including a role in regulation of lipid metabolism 1 5 .
These CLA activities are associated with the conjugated double bond system. CLAs are found naturally and are especially present in ruminant fats such as beef tallow and milk fat 1 . However, the CLA level in these foodstuffs is around 1 w/w , which prevents use of the natural fats as health-promoting foods containing CLAs. Therefore, oils that include CLAs are currently prepared from alkali-isomerization of vegetable oils such as safflower oil and these products are marketed as health supplements 6, 7 .
Conjugated fatty acids other than CLAs also exist in nature, including seed oils of plants that include conjugated triene fatty acids such as α-eleostearic acid α-ESA; 9c,11t,13t-18:3, Fig. 1 and jacaric acid JA; 8c,10t,12c-18:3, Fig. 1 at levels of 30 to 80 w/w 8 10 . We are particularly interested in seed oils including conjugated linolenic acids CLnAs , which are the only conjugated fatty acids that can be prepared from natural sources in bulk, and we have previously shown that α-ESA which is a CLnA has a stronger anti-tumor effect than CLA in vitro and in vivo 11 . α-ESA also has useful physiological effects and we have shown that the conjugated triene in α-ESA is partially saturated at the Δ13 position and converted to 9c,11t-CLA, which has a conjugated diene, in rats. The Δ13 saturation is an NADPH-dependent enzymatic reaction that occurs most rapidly in rat liver and small intestine 12 14 .
In our recent studies, we showed that the anti-tumor activity of CLnAs is stronger than that of CLAs, and that JA Abstract: We have shown previously that jacaric acid (JA; 8c,10t,12c-18:3), which has a conjugated triene system, has a strong anti-tumor effect. However, the characteristics of absorption and metabolism of JA have yet to be determined in vivo, and the details of absorption and metabolism of JA in the small intestine are particularly unclear. This information is required for effective use of JA in humans. Therefore, in this study we examined absorption and metabolism of JA using cannulation of the thoracic duct in rats. Emulsions of two test oils, jacaranda seed oil and tung oil, which contain JA and α-eleostearic acid (α-ESA; 9c,11t,13t-18:3), respectively, were administered to rats and lymph from the thoracic duct was collected over 24 h. We examined the rate of absorption of JA and possible conversion to a conjugated linoleic acid (CLA) containing a conjugated diene system. The positional isomerism of the CLA produced by JA metabolism was determined using gas chromatography-electron impact/mass spectrometry. The rate of absorption and percentage conversion of JA were compared with those of α-ESA. We found that JA is rapidly absorbed and converted to a CLA in rats and that the percentage conversion of JA was lower than that of α-ESA. This is the first report on the absorption and metabolism of JA and this information may be important for application of JA as a functional food.
Key words: conjugated fatty acid, conjugated linolenic acid, conjugated linoleic acid, jacaric acid, lymph had the strongest effect among CLnAs 15 . JA is a natural product that is present in jacaranda seed 10 and may have applications in humans as a useful physiologically active fatty acid. However, the characteristics of absorption and metabolism of JA have yet to be determined in vivo, particularly in the small intestine. This information is very important for effective use of JA in humans. Additionally, it is of interest to determine whether the conjugated triene system of JA undergoes a saturation reaction in vivo. We are interested in this reaction because it is a rare example of fatty acid metabolism involving saturation of a double bond. For these reasons, we investigated the absorption and metabolism of JA in rat intestine using a previously described lipid absorption assay based on collection of lymph from the thoracic duct 13, 16 .
The absorption and metabolism of JA in rat intestine were examined using two test oils: jacaranda seed oil JSO , which contains a triacylglycerol TG form of JA; and tung oil TO , which contains a TG form of α-ESA, an isomer of JA. First, we examined whether JA was absorbed in rats. To determine if JA is converted to a CLA, the structure of the metabolite was determined using gas chromatography-electron impact/mass spectrometry GC-EI/MS 12, 13 .
The rate of absorption and conversion rate of JA were then compared with those of α-ESA. The results showed that JA is rapidly absorbed and converted to a CLA in rats and that the percentage conversion of JA is lower than that of α-ESA. This is the first report on the absorption and metabolism of JA and the findings may be useful for application of JA as a functional food.
EXPERIMENTAL PROCEDURES

Materials
Trimethylsilyldiazomethane 10 in hexane, v/v was purchased from GL Sciences, Inc. Tokyo, Japan . Sodium methoxide/methanol 1 mmol/L solutions was purchased from Wako Pure Chemicals Industries Osaka, Japan . JSO was a kind gift from the Miyazaki Prefectural Government Miyazaki, Japan . TO was kindly provided by The Nisshin OilliO Group Tokyo, Japan . JA 99 purity and α-ESA 99 purity were purchased from Larodan Fine Chemicals AB Malmö, Sweden . 9c,11t-CLA 98 purity was obtained from Cayman Chemical Co. Ann Arbor, MI .
Methods
Animals and treatments
All procedures were performed in accordance with the Animal Experiment Guidelines of Tohoku University. The animal protocol was approved by the Animal Use Committee at Tohoku University.
Cannulation of the thoracic duct of rats
Operations and maintenance of rats and all other procedures were performed as described previously 13, 16 . Nineweek-old male Sprague-Dawley rats were obtained from CLEA Japan Tokyo, Japan . After acclimatization with MF Standard Rodent Chow Oriental Yeast and distilled water free access for 1 week, a cannula SV35, Dural Plastics, Tokyo, Japan was inserted into the left thoracic channel to collect lymphatic fluid and a catheter SP-55, Dural Plastics, Tokyo, Japan was also inserted into the stomach. After surgery, each rat was placed in a restraining cage in a warm recovery room. A physiological solution containing 139 mmol/L glucose and 85 mmol/L NaCl was continuously infused overnight at a rate of 3 mL/h through the stomach cannula. The same solution was also provided as drinking water. The next morning, after collection of lymph for 2 h as a blank control, the rats were infused with 3 mL of an emulsion as a single bolus through the stomach catheter. Test emulsions containing 200 mg of the test oils JSO or TO , 50 mg of fatty acid-free albumin, and 200 mg of sodium taurocholate were prepared by ultrasonication. After infusing the emulsion into the rats, infusion of the glucose/NaCl solution was continued. Lymph was collected in an EDTA-containing tube for analysis at the following intervals after test-oil infusion: 0-2, 2-4, 4-6, 6-8 and 8-24 h. After lymph flow was measured, lymph was stored at 30 until analysis.
Gas chromatography GC analysis
Total lipids from each lymph sample were extracted using the Bligh & Dyer procedure 17 . A volume of 2 mL of MeOH:CHCl 3 2:1 v/v containing butylated hydroxytoluene BHT was added to 400 μL of each lymph sample and mixed by vortex for 2 min. Then 1 mL of MeOH:CHCl 3 1:1 v/v containing BHT was added, mixed by vortex for 2 min, and centrifuged for 5 min at 4 and 907g Takara Tomy, Japan . The lower layer was transferred to another tube and 1 mL of CHCl 3 containing BHT was added to the upper layer, mixed by vortex for 2 min, and centrifuged. This step was repeated three times. Total lipids were dried under a stream of nitrogen gas. Total lipids or TO or JSO test oils and a known amount of heptadecanoic acid 17:0 Sigma, St. Louis, MO as an internal standard were methylated by addition of trimethylsilyldiazomethane for 30 min and sodium methoxide/methanol for 10 min at room temperature to prepare fatty acid methyl esters FAMEs 13, 18 . The product was subjected to GC GC-2014, Shimadzu, Kyoto, Japan using a flame ionization detector and a Supelco wax-10 fused silica capillary column 60 m 0.32 mm, 0.25 μm film thickness, Supelco, Bellefonte, PA using previously described GC conditions 13, 14 . Peak components were identified by comparing retention times with those of commercial FAMEs Funakoshi, Tokyo . Reference standards were used to identify JA, α-ESA and 9c,11t-CLA 14, 19 . The peak for heptadecanoic acid 17:0 was used as a basis for measuring the levels of fatty acids 14, 19 . The fatty acid compositions of the test oils are shown in Table 1 .
The absorption and metabolism of Jacaric acid 2.2.4 Structure determination of CLA To determine the positional isomerism of the CLA produced by JA metabolism, total lipids in the lymph of JSOor TO-treated rats 0-2 h after administration were identified by analyzing the corresponding fatty acid 4,4-dimethyloxazoline DMOX derivatives by GC-EI/MS GCMS-QP5050A, Shimadzu Corporation, Kyoto 13, 14 . DMOX derivatives were prepared after freeing the fatty acids from total lipids in the lymph. The free fatty acids were mixed with 2-amino-2-methyl-1-propanol in a test tube, which was then purged with nitrogen gas, screw-capped and heated at 170 . After 30 min, the tube was cooled and a saturated NaCl solution and n-hexane were added, followed by vigorous shaking. After centrifugation, the hexane phase was dried under a stream of nitrogen gas and the dried residue was then redissolved in an adequate amount of n-hexane. GC-EI/MS was performed using a GC system GC-17A, Shimadzu equipped with a Supelcowax-10 fused silica capillary column coupled to an electron impact mass spectrometer GCMS-QP5050A, Shimadzu . Helium was used as the carrier gas. The injector temperature was 170 . The oven temperature was programmed to match the temperature used in the corresponding GC analysis 13, 14 . The temperature of the ion source was 250 .
Electron impact mass spectra were recorded at 70 eV and analyzed using the CLASS 5000 data system Shimadzu .
Statistical analysis
Each result is shown as the mean SE. A Dunnett multiple-comparison test or two-tailed unpaired Student t-test was performed to compare findings between groups. A difference was considered to have significance at p 0.05.
RESULTS
The aim of the study was to determine the absorption and metabolism properties of JA in the rat small intestine. JSO containing the triacylglycerol form of JA was used as the test oil Table 1 and TO containing the triacylglycerol form of α-ESA was used as a comparison oil Table 1 . CLA was not detected in JSO or TO Table 1 . There were no conjugated fatty acids in rat lymph immediately before administration of the oils, based on GC analysis Fig. 2A . Peaks due to the administered oils appeared in the chromatogram of the lymph 2 h after administration Fig. 2B , C . Peaks for α-ESA and 9c,11t-CLA appeared in the chromatogram of lymph from rats administered TO Fig. 2B , showing that α-ESA was converted to 9c,11t-CLA in the rat intestine. Peaks for JA and compound X, which had the same retention time as 9c,11t-CLA, ap- FAMEs prepared from test emulsion were analyzed by GC.
-, not detected (＜0.1%).
Fig. 1 Chemical structures of conjugated fatty acids.
peared in the chromatogram of lymph from rats administered JSO Fig. 2C , suggesting that JA may have been converted to a CLA. The structure of compound X formed by JA metabolism was determined using GC-EI/MS. FAMEs of total lipids in lymph from the JSO group were converted to DMOX derivatives and analyzed using GC-EI/MS, in which a fragment due to the presence of conjugated double bond was apparent. The GC-EI/MS spectrum of the DMOX derivative of JA and compound X in lymph of the JSO group and 9c,11t-CLA standard had fragments of m/z 113 and 126, due to fatty acid DMOX derivatives Fig. 3 . The presence of JA in lymph of the JSO group was confirmed by the position of the double bonds Fig. 3A . The GC-EI/MS spectrum of the DMOX derivative of compound X had a molecular ion with a m/z ratio of 333 and fragments of m/z 168 and 248, due to allylic cleavage of the fatty acid chain Fig. 3B . The mass spectrum also exhibited differences of 12 mass . These results show that compound X was 8,10-CLA. In addition, because 8,10-CLA and 9c,11t-CLA had the same retention time, the GC-EI/MS spectrum of the DMOX derivative of compound X and 9c,11t-CLA standard were compared. The spectrum of the DMOX derivative of compound X differed from that of 9c,11t-CLA Fig. 3B , C , indicating that JA was converted to a CLA through a Δ12-saturation reaction in the small intestine. Next, the lymphatic recovery and conversion rate of JA were compared with those of α-ESA. Since α-ESA is converted to 9c,11t-CLA, the lymphatic recovery of α-ESA in TO-treated rats was determined as the total of recovered α-ESA and 9c,11t-CLA. Based on this approach, the lymphatic recovery of α-ESA in TO-treated rats was 62 at 8 h after administration and 86 after 24 h Fig. 4A : 57 of administered α-ESA was recovered unchanged and 29 was collected as 9c,11t-CLA due to metabolism of α-ESA; therefore, about 34 of α-ESA absorbed in rats was converted to 9c,11t-CLA. JA is converted to 8,10-CLA in vivo, as shown above, and therefore the lymphatic recovery of JA in JSO-treated rats was determined as the total of recovered JA and 8,11-CLA. The lymphatic recovery of JA in JSO-treated rats was 76 at 8 h after administration and 89 after 24 h Fig. 4B : 77 of administered JA was recovered unchanged and 12 was collected as 8,10-CLA; therefore, about 13 of JA absorbed in rats was converted to 8,10-CLA. Overall, the results show that most administered α-ESA and JA was absorbed in 24 h.
The lymphatic recoveries of α-ESA and JA were also calculated for different time intervals Fig. 5 . There was a significant difference between recoveries of unconverted CLnAs in the JSO and TO groups for all intervals Fig. 5A . Recovery of unconverted JA was significantly greater than that of unconverted α-ESA in all intervals. Overall, these results show that the absorption rate of unconverted α-ESA was lower than that of unconverted JA. A comparison of the percentage conversion of α-ESA and JA to CLA of α-ESA to CLA was about two fold higher than conversion of JA, and thus unchanged JA remains at a higher concentration than unchanged α-ESA following administration in rats.
DISCUSSION
In our previous studies, we have shown that the anti-tumor activity of CLnAs is stronger than that of CLAs and that JA has the strongest effect among CLnAs 11, 15 . These results suggest that JA may be a useful physiologically active substance that may have important applications in humans. Therefore, in this study we examined the absorption and metabolism of JA, with the goal of obtaining information that will permit use of JA in humans. Our results provide new findings concerning the absorption and metabolism of JA. JA was detected in lymph of rats after administration Fig. 2 , which indicates that JA was absorbed, similarly to previous findings for other molecules with conjugated triene systems: α-ESA and punicic acid PA; 9c,11t,13c-18:3 13 . Moreover, we have previously shown that α-ESA and PA are metabolized to 9,11-CLA in rats 12, 13 . In this study, we showed that JA was metabolized to 8,10-CLA based on findings in GC-EI/MS Fig. 3 as well as α-ESA and PA. The majority of JA administered to rats was absorbed as JA, but some JA is converted to CLA in the small intestine. This conversion reaction occurs at the double bond at the Δ12 position and is a specific reaction in fatty acid metabolism. We previously showed a similar reaction at the double bond at the Δ13 position of α-ESA and PA 12, 13 .
Therefore, these results suggest that the double bond distal to the carboxyl group in the conjugated triene structure is selectively saturated in this reaction. Conversion of JA to CLA was detected two hours after administration Fig. 2 , which indicates that the conversion reaction is very fast compared with reactions such as auto-oxidation. Therefore, it is likely that this reaction is catalyzed by an enzyme in vivo for JA, as well as for α-ESA and PA 13, 14 , but we currently cannot identify the enzyme.
However, the Δ13-saturation reactionis probably mediated by a type of oxidoreductase, since these enzymes catalyze NADPH-dependent saturation of double bonds 14 . The reaction is also similar to that in a metabolic pathway of leukotriene B 4 LTB 4 , which is an activator of leukocytes and contains a conjugated triene structure. Although ω-oxidation is the major deactivation pathway of LTB 4 in leukocytes, another pathway proceeding by reduction of conjugated double bonds has been reported 20 22 . In the reductive pathway, LTB 4 is converted to 12-oxo-LTB 4 by LTB 4 12-hydroxydehydrogenase, which is distributed in various porcine tissues and leukocytes 20, 21 . 12-oxo-LTB 4 is then converted into 10,11,14,15-tetrahydro-12-oxo-LTB 4 conjugated dienoic acid by another enzyme, which has yet to be identified 20 22 . The double bond saturation reaction is also similar to that occurring in the metabolic conversion of retinol to 13,14-dihydroretinol 23, 24 . Therefore, we speculate that either a novel enzyme recognizing conjugated trienoic acids or the enzyme active in the LTB 4 or retinol reductive pathway may convert JA a conjugated triene to 8,10-CLA a conjugated diene through Δ12-saturation. We identified 8,10-CLA as a metabolite of JA Fig. 3 . CLAs have useful physiologic activity 1 5 , but the physiological function of 8,10-CLA is unknown. Therefore, the physiologic activity of JA might be responsible for that of 8,10-CLA. Percentage conversion of JA was lower than that of α-ESA Figs. 4, 5 and we previously showed that the conversion rate of α-ESA was higher than that of PA 13 .
The difference between α-ESA and PA may be explained by the double bond configuration, since the double bond at the Δ13 position of α-ESA is a trans isomer, whereas that of PA is cis. Thus, a trans double bond may more easily undergo enzymatic Δ13-saturation. This is consistent with the slow saturation reaction of JA, in which the double bond is in the cis configuration. We previously showed that CLnAs have a stronger antitumor effect than CLAs in vivo and in vitro 11 . This may be because CLnAs are not readily metabolized, which may also explain the strong physiological effects of JA, and it is of note that JA has a stronger anti-tumor effect than α-ESA 15 . However, the relationship between metabolic response and physiological benefits is uncertain and further work is needed to address this issue. Our results clearly show that JA is absorbed in the rat intestine more rapidly than α-ESA Figs. 4, 5 and we have previously shown that the rate of absorption of α-ESA was slower than that of α-linolenic acid 9c,12c,15c-18:3 13 . We have also shown that JA is absorbed in cultured cells faster than α-ESA 15 . These differences may be related to the polarity of the molecules, with JA showing faster absorption because the polarity of JA is lower than that of α-ESA. In this study, the percentage of JA in jacaranda seed oil was different compared with that of α-ESA in tung oil Table 1 . The difference of fatty acid levels in the emulsion has the possibility of influencing the lymphatic recovery. However, we previously showed that the difference of CLA levels in the emulsion did not give the substantial change to the lymphatic recovery of CLA 16 . Therefore, it was thought that there was no big influence in the lymphatic recovery of conjugated fatty acids in dosage of this experiment 200 mg triacylglycerol/rat .
CONCLUSION
In this study, we examined the absorption and metabolism of JA. We showed that JA is rapidly absorbed and con-
